BeiGene, Ltd., 10% Owner at LEAP THERAPEUTICS, INC. (LPTX), bought 2,543,800 shares at $2.85 ($7.2M) on 2021-09-24, disclosed to the SEC on 2021-09-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.